Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,102,278
  • Shares Outstanding, K 29,824
  • Annual Sales, $ 2,923 M
  • Annual Income, $ 4,246 M
  • 60-Month Beta 0.93
  • Price/Sales 4.28
  • Price/Cash Flow 26.51
  • Price/Book 1.48
Trade BIO with:

Options Overview Details

View History
  • Implied Volatility 38.69% ( +1.17%)
  • Historical Volatility 44.91%
  • IV Percentile 35%
  • IV Rank 36.82%
  • IV High 56.49% on 10/10/22
  • IV Low 28.31% on 12/23/21
  • Put/Call Vol Ratio 0.60
  • Today's Volume 8
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 1.36
  • Today's Open Interest 5,719
  • Open Int (30-Day) 5,443

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 3.45
  • Number of Estimates 2
  • High Estimate 3.46
  • Low Estimate 3.44
  • Prior Year 3.21
  • Growth Rate Est. (year over year) +7.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
371.74 +7.42%
on 11/07/22
450.81 -11.42%
on 11/11/22
+21.11 (+5.58%)
since 11/04/22
3-Month
344.63 +15.87%
on 10/31/22
514.25 -22.35%
on 09/12/22
-78.60 (-16.45%)
since 09/06/22
52-Week
344.63 +15.87%
on 10/31/22
770.76 -48.19%
on 12/09/21
-343.05 (-46.21%)
since 12/06/21

Most Recent Stories

More News
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a Fireside...

BIO : 399.59 (-1.53%)
Bio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Down

Bio-Rad's (BIO) third-quarter revenues decline mainly as a result of lower COVID-related sales compared with the year-ago period.

BIO : 399.59 (-1.53%)
CNC : 85.93 (-0.49%)
MEDP : 203.72 (-0.87%)
ELV : 528.40 (+1.16%)
Bio-Rad Laboratories (BIO) Surpasses Q3 Earnings Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of 0.39% and 1.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BIO : 399.59 (-1.53%)
ZVIA : 4.12 (-3.74%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 399.59 (-1.53%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 399.59 (-1.53%)
Bio-Rad Reports Third-Quarter 2022 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2022....

BIO : 399.59 (-1.53%)
Medical Device Stocks' Q3 Earnings on Oct 27: LH, BIO & More

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, BIO, BAX, DXCM and WST are likely to fare this time....

LH : 234.15 (-0.95%)
BAX : 51.51 (+0.41%)
DXCM : 116.83 (+0.23%)
BIO : 399.59 (-1.53%)
WST : 234.99 (-1.86%)
Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards?

Owing to the impact of the Russia-Ukraine war situation, supply chain constraints, as well as the inflationary situation, we expect Bio-Rad's (BIO) Life Science arm to experience a year-over-year decline....

MCK : 378.04 (-1.15%)
HUM : 546.35 (-0.20%)
CRL : 211.21 (-1.81%)
BIO : 399.59 (-1.53%)
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the third quarter of 2022 on Thursday,...

BIO : 399.59 (-1.53%)
Walgreens (WBA) to Report Q4 Earnings: What's in the Cards?

Walgreens (WBA) is expected to have registered growth in Q4 in its U.S. retail pharmacy business, banking on demand for vaccinations and tests amid the ongoing series of contagious virus spread.

MCK : 378.04 (-1.15%)
ABMD : 377.95 (-0.07%)
BIO : 399.59 (-1.53%)
WBA : 40.59 (-1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and...

See More

Key Turning Points

3rd Resistance Point 420.04
2nd Resistance Point 416.40
1st Resistance Point 411.10
Last Price 399.59
1st Support Level 402.16
2nd Support Level 398.52
3rd Support Level 393.22

See More

52-Week High 770.76
Fibonacci 61.8% 607.98
Fibonacci 50% 557.70
Fibonacci 38.2% 507.41
Last Price 399.59
52-Week Low 344.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar